Leptomeningeal melanoma-A case series in the era of modern systemic therapy

Related Experiment Video

Updated: Feb 21, 2026

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
07:14

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

Published on: May 23, 2025

1.9K

Malmaruha Arasaratnam1, Angela Hong2,3,4, Brindha Shivalingam2,4,5

  • 1Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia.

Pigment Cell & Melanoma Research
|October 5, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.6K
A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

6.6K

Related Experiment Videos

Last Updated: Feb 21, 2026

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
07:14

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

Published on: May 23, 2025

1.9K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.6K
A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

6.6K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

6.3K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K

Articles linked to this work by shared authors, journal, and citation graph.

Predictors of Immediate Therapeutic Lymph Node Dissection Instead of Index Lymph Node After Neoadjuvant Checkpoint Inhibitors: Lessons Learned from the PRADO Trial.

Annals of surgical oncology·2026

Impact of adjuvant therapy on melanoma-specific survival in elderly patients with high-risk resected melanoma: a multicenter international retrospective study.

Journal for immunotherapy of cancer·2026

Anti-PD-1 Therapy and Long-Term Toxic Effects Among Patients With Melanoma.

JAMA network open·2026

Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

Nature medicine·2026

Reactive Oxygen Species in Cardiovascular and Hematological Diseases: Mechanisms and Therapeutic Strategies.

Cureus·2026

Artificial Intelligence Triage of Urgent Versus Non-Urgent CT Brain Findings to Support Expedited Emergency Department Disposition: A Retrospective Validation Study.

Emergency medicine Australasia : EMA·2026

High-Fat Diet Intake Enhances Ultraviolet-Induced Melanin Production in the Skin.

Pigment cell & melanoma research·2026

Mutations in Chromatin Regulator Genes Associate With TMB and Immunotherapy Response in Melanoma.

Pigment cell & melanoma research·2026

The Safety of Melasma Treatment in Vitiligo Patients: An International E-Delphi Study.

Pigment cell & melanoma research·2026

Construction of an EMT-Related Prognostic Model for Melanoma and Functional Validation of the EMT-Associated Gene BGN.

Pigment cell & melanoma research·2026

Melanin as a Multifunctional Molecular System: Biosynthesis, Genetics, and Functional Roles in Livestock Species.

Pigment cell & melanoma research·2026

Immune-Excluded Mucosal Melanoma: Spatial Mechanisms of Checkpoint Resistance and Biomarker-Guided Therapeutic Opportunities.

Pigment cell & melanoma research·2026

Exosome-Coated Dendrimer Nanogels as a Therapeutic Vaccine for CT Imaging-Guided Chemoimmunotherapy of Pancreatic Cancer.

Polymer science & technology (Washington, D.C.)·2026

Enhancing Drug Delivery and Efficacy in Stroke via Supramolecular Nanoparticle Systems.

ACS omega·2026

Invisible shield: sprayable supramolecular antimicrobial microscale films for preventing wound and medical device infections.

npj biomedical innovations·2026

Favorable clinical and safety outcomes independent of baseline skin disease burden in treatment-naïve blastic plasmacytoid dendritic cell neoplasm treated with tagraxofusp: a subgroup analysis of a pivotal trial.

Acta haematologica·2026

Antiviral nanoparticles: mechanisms, biomedical applications and clinical translation toward next-generation therapies.

Preparative biochemistry & biotechnology·2026

Iron-Based Contrast for the Heart: Clinical Promise of Ferumoxytol-Enhanced CMR.

Current cardiovascular imaging reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us